Blueprint Medicines Corp (BPMC)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | BPMC | HALO | NUVL | ||
| Company | Blueprint Medicines Corp | Halozyme Therapeutic | Nuvalent Inc Cl A | ||
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | ||
| Open | 129.35 | 70.94 | 111.01 | ||
| High | 129.55 | 71.90 | 111.28 | ||
| Low | 129.30 | 69.10 | 106.36 | ||
| Latest | 129.46 | 69.22 | 106.44 | ||
| Change | +0.18 | -2.07 | -5.55 | ||
| % Change | +0.14% | -2.90% | -4.96% | ||
| Volume | 2,980,900 | 1,782,000 | 448,500 | ||
| 20-Day Average Volume | 4,470,280 | 1,615,375 | 537,115 | ||
| Previous Close | 129.28 | 71.29 | 111.99 | ||
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | ||
| Has Options | No | Yes | Yes | ||
| Technicals | |||||
| 20-Day Moving Average | 128.60 | 70.92 | 103.75 | ||
| 20-Day Raw Stochastic | 88.49% | 25.67% | 62.45% | ||
| 20-Day Relative Strength | 73.17 | 49.14 | 52.95 | ||
| Weighted Alpha | +17.08 | +24.00 | +39.90 | ||
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | ||
| Previous Opinion | 100% Buy | 88% Buy | 88% Buy | ||
| Last Month's Opinion | 100% Buy | 24% Buy | 80% Buy | ||
| Performance | |||||
| 5-Days | |||||
| %Chg | +0.10% since 07/10/25 | -3.62% since 01/15/26 | +0.26% since 01/15/26 | ||
| Low | 129.00 on 07/11/25 | 69.10 on 01/23/26 | 101.25 on 01/20/26 | ||
| High | 129.65 on 07/16/25 | 72.33 on 01/21/26 | 113.01 on 01/22/26 | ||
| 1-Month | |||||
| %Chg | +0.96% since 06/17/25 | +1.26% since 12/23/25 | +1.54% since 12/23/25 | ||
| Low | 128.00 on 06/20/25 | 67.02 on 12/31/25 | 95.50 on 01/05/26 | ||
| High | 129.65 on 07/16/25 | 75.59 on 01/07/26 | 113.01 on 01/22/26 | ||
| 3-Month | |||||
| %Chg | +52.86% since 04/17/25 | +3.49% since 10/23/25 | +17.11% since 10/23/25 | ||
| Low | 83.27 on 04/22/25 | 61.22 on 12/11/25 | 89.02 on 11/05/25 | ||
| High | 129.65 on 07/16/25 | 75.59 on 01/07/26 | 113.01 on 01/22/26 | ||
| 6-Month | |||||
| %Chg | +17.64% since 01/17/25 | +18.20% since 07/23/25 | +32.26% since 07/23/25 | ||
| Low | 73.04 on 04/09/25 | 57.67 on 07/29/25 | 71.13 on 08/08/25 | ||
| High | 129.65 on 07/16/25 | 79.50 on 09/23/25 | 113.01 on 01/22/26 | ||
| Key Statistics | |||||
| Market Capitalization, $K | 8,360,786 | 8,383,490 | 8,142,457 | ||
| Shares Outstanding, K | 64,582 | 117,597 | 72,707 | ||
| Annual Sales | 508,820,000 | 1,015,320,000 | 0 | ||
| Annual Net Income | -67,090,000 | 444,090,000 | -260,760,000 | ||
| Last Quarter Sales | 149,410,000 | 354,260,000 | 0 | ||
| Last Quarter Net Income | 500,000 | 175,230,000 | -122,440,000 | ||
| 60-Month Beta | 0.89 | 0.94 | 1.32 | ||
| Per-Share Information | |||||
| Most Recent Earnings | -0.74 on 05/01/25 | 1.72 on 11/03/25 | -1.70 on 10/30/25 | ||
| Latest Earnings Date | 08/07/25 | 02/17/26 | 02/26/26 | ||
| Most Recent Dividend | N/A | N/A | N/A | ||
| Next Ex-Dividends Date | N/A | N/A | N/A | ||
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 13.48 | 0.00 | ||